Regen BioPharma Inc (RGBP)
0.085
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Regen BioPharma Debt to Equity Ratio: -0.1394 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.1394 |
| March 31, 2024 | -0.134 |
| December 31, 2023 | -0.1362 |
| September 30, 2023 | -0.1482 |
| June 30, 2023 | -0.1216 |
| March 31, 2023 | |
| December 31, 2022 | -0.1047 |
| September 30, 2022 | -0.1585 |
| June 30, 2022 | -0.1895 |
| March 31, 2022 | -0.0391 |
| December 31, 2021 | -0.2793 |
| September 30, 2021 | -0.2657 |
| June 30, 2021 | -0.2258 |
| March 31, 2021 | -0.5022 |
| December 31, 2020 | -0.4635 |
| September 30, 2020 | -0.3551 |
| June 30, 2020 | -0.296 |
| March 31, 2020 | -0.2038 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.287 |
| September 30, 2019 | -0.1968 |
| June 30, 2019 | -0.1502 |
| March 31, 2019 | -0.2091 |
| December 31, 2018 | -0.1892 |
| September 30, 2018 | -0.157 |
| June 30, 2018 | -0.143 |
| March 31, 2018 | -0.1202 |
| December 31, 2017 | -0.12 |
| September 30, 2017 | -0.1319 |
| June 30, 2017 | -0.1238 |
| March 31, 2017 | -0.2342 |
| December 31, 2016 | -1.575 |
| September 30, 2016 | -0.4422 |
| June 30, 2016 | -0.7422 |
| March 31, 2016 | -1.121 |
| December 31, 2015 | -7.647 |
| September 30, 2015 | -2.292 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.5022
Minimum
Mar 2021
-0.0391
Maximum
Mar 2022
-0.225
Average
-0.1966
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.1702M |
| Total Liabilities (Quarterly) | 5.328M |
| Shareholders Equity (Quarterly) | -5.158M |
| Current Ratio | 0.0286 |
| Net Debt Paydown Yield | -5.09% |